Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Shares Outstanding (2017 - 2025)

Catheter Precision (VTAK) has disclosed Shares Outstanding for 9 consecutive years, with $2229.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding changed N/A to $2229.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2229.0, a N/A change, with the full-year FY2024 number at $12656.0, up 176.45% from a year prior.
  • Shares Outstanding was $2229.0 for Q3 2025 at Catheter Precision, down from $12656.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $646.6 million in Q2 2022 to a low of $2229.0 in Q3 2025.
  • A 5-year average of $44.1 million and a median of $536767.0 in 2023 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: skyrocketed 1017304.29% in 2022, then crashed 100.0% in 2023.
  • Catheter Precision's Shares Outstanding stood at $140190.0 in 2021, then skyrocketed by 1015925.39% to $1.4 billion in 2022, then tumbled by 100.0% to $12656.0 in 2023, then changed by 0.0% to $12656.0 in 2024, then plummeted by 82.39% to $2229.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Shares Outstanding are $2229.0 (Q3 2025), $12656.0 (Q2 2025), and $487821.0 (Q1 2025).